510(k) K250741

Evidence MultiSTAT DOA Urine MultiPlex by Randox Laboratories Limited — Product Code DJG

K250741 is an FDA 510(k) premarket notification submitted by Randox Laboratories Limited for the device "Evidence MultiSTAT DOA Urine MultiPlex". The FDA issued a decision of Substantially Equivalent on January 23, 2026. The device falls under product code DJG (Enzyme Immunoassay, Opiates), a Class II device regulated under 21 CFR 862.3650. Randox Laboratories Limited has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
January 23, 2026
Date Received
March 11, 2025
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Enzyme Immunoassay, Opiates
Device Class
Class II
Regulation Number
862.3650
Review Panel
TX
Submission Type